Angiogenesis inhibitors in the treatment of small cell and non-small cell lung cancer

被引：12

作者：

Blackhall, FH

Shepherd, FA

机构：

[1] Princess Margaret Hosp, Toronto, ON M5G 2M9, Canada

[2] Christie Hosp NHS Trust, Dept Med Oncol, Manchester M20 4BX, Lancs, England

[3] Univ Toronto, Toronto, ON M5G 2M9, Canada

来源：

HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA | 2004年 / 18卷 / 05期

关键词：

D O I：

10.1016/j.hoc.2004.06.005

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Angiogenesis is believed to play a critical role in cancer; however, antiangiogenic therapy has not been demonstrated to improve the survival of patients who have lung cancer. In this article, the evidence that supports a role for angiogenesis in the pathogenesis of lung cancer, trials of antiangiogenic agents in lung cancer performed to date, and the lessons learned from these studies are discussed.

引用

收藏

页码：1121 / +

页数：22

相关论文

共 93 条

[1]

ALTORKI NK, 2002, P AN M AM SOC CLIN, V21, pA26

[2] Assessment of pharmacodynamic vascular response in a phase I trial of combretastatin A4 phosphate [J].

Anderson, HL ;

Yap, JT ;

Miller, MP ;

Robbins, A ;

Jones, T ;

Price, PM .

JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (15) :2823-2830

[3] Loss of collagenase-2 confers increased skin tumor susceptibility to male mice [J].

Balbín, M ;

Fueyo, A ;

Tester, AM ;

Pendás, AM ;

Pitiot, AS ;

Astudillo, A ;

Overall, CM ;

Shapiro, SD ;

López-Otín, C .

NATURE GENETICS, 2003, 35 (03) :252-257

[4]

BILENKER JH, 2003, P AN M AM SOC CLIN, V223, P222

[5]

BISSETT D, 2002, P AN M AM SOC CLIN, V21, pA296

[6]

Blackhall FH, 2003, CLIN CANCER RES, V9, P2241

[7] Heparan sulfate proteoglycans and cancer [J].

Blackhall, FH ;

Merry, CLR ;

Davies, EJ ;

Jayson, GC .

BRITISH JOURNAL OF CANCER, 2001, 85 (08) :1094-1098

[8] Human endostatin inhibits growth of human non-small-cell lung cancer in a murine xenotransplant model [J].

Boehle, AS ;

Kurdow, R ;

Schulze, M ;

Kliche, U ;

Sipos, B ;

Soondrum, K ;

Ebrahimnejad, A ;

Dohrmann, P ;

Kalthoff, H ;

Henne-Bruns, D ;

Neumaier, M .

INTERNATIONAL JOURNAL OF CANCER, 2001, 94 (03) :420-428

[9] Antiangiogenic therapy of experimental cancer does not induce acquired drug resistance [J].

Boehm, T ;

Folkman, J ;

Browder, T ;

OReilly, MS .

NATURE, 1997, 390 (6658) :404-407

[10] Tumour necrosis factor-α and transforming growth factor-β are significantly associated with better prognosis in non-small cell lung carcinoma: putative relation with BCL-2-mediated neovascularization [J].

Boldrini, L. ;

Calcinai, A. ;

Samaritani, E. ;

Pistolesi, F. ;

Mussi, A. ;

Lucchi, M. ;

Angeletti, C. A. ;

Basolo, F. ;

Fontanini, G. .

BRITISH JOURNAL OF CANCER, 2000, 83 (04) :480-486

← 1 2 3 4 5 6 7 8 9 10 →